Skip to main content

ECARX Holdings Inc.

For the period ended Jul 17, 2026. Filed Jul 17, 2026.

View on SEC.gov

About this filing

What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.

Jul 17, 2026 · Filed Jul 17, 2026

Use the contents to explore the available documents and sections.

ECX$0.80+0.2%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

EX-99.1 · 1.Effect

  1. Effect

Subject to the terms and conditions of this Deed, the following amendments shall be deemed to have taken effect on the Effective Date:

(a)in accordance with Clause 6.7 (Amendment; Waiver) of the SPDB Initial Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(b)in accordance with Clause 6.7 (Amendment; Waiver) of the Nomura Initial Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(c)in accordance with Clause 6.7 (Amendment; Waiver) of the CNCB Additional Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(d)in accordance with Clause 6.7 (Amendment; Waiver) of the ICBCI Additional Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(e)in accordance with Clause 6.7 (Amendment; Waiver) of the ECCB Additional Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(f)in accordance with Clause 6.7 (Amendment; Waiver) of the ECMS Additional Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions);

(g)in accordance with Clause 6.7 (Amendment; Waiver) of the EHZF Additional Note Instrument, the Note Conditions set out therein shall be amended and restated for the benefit of the parties thereto as set out in Clause 2.2 (Amendment and Restatement of Note Conditions); and

(h)in accordance with Clause 17.5 (Amendments and Waivers) of the Note Purchase Agreement, the Note Purchase Agreement shall be amended for the benefit of all parties thereto as set out in Clause 2.3 (Amendments to Note Purchase Agreement),

and each Party shall have the rights and take on the obligations ascribed to it under each of the Initial Note Instruments, each of the Additional Note Instruments and the Note Purchase Agreement, each as amended by this Clause 2 (Amendments).

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.